Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xenon Pharmaceuticals Inc XENE

Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more

Recent & Breaking News (NDAQ:XENE)

Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2021

Xenon Pharmaceuticals to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference

GlobeNewswire August 10, 2021

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results and Provide Corporate Update

GlobeNewswire August 4, 2021

Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021

GlobeNewswire July 13, 2021

Xenon Pharmaceuticals Announces Completion of Patient Randomization in XEN1101 Phase 2b "X-TOLE" Clinical Trial and Announces Upcoming Investor Webinar with Leading Epilepsy Key Opinion Leaders

GlobeNewswire July 7, 2021

Xenon Pharmaceuticals Provides Corporate Update Following its Annual Meeting of Shareholders

GlobeNewswire June 3, 2021

Xenon Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference

GlobeNewswire May 31, 2021

Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire May 11, 2021

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2021 Financial Results and Provide Corporate Update

GlobeNewswire May 4, 2021

Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire April 8, 2021

Xenon Pharmaceuticals to Participate in the Stifel 3rd Annual CNS Day

GlobeNewswire March 29, 2021

Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire March 12, 2021

Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering

GlobeNewswire March 10, 2021

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

GlobeNewswire March 9, 2021

Xenon Pharmaceuticals Announces Collaboration with Researchers at Icahn School of Medicine at Mount Sinai to Conduct a Phase 2 Study of XEN1101 for the Treatment of Major Depressive Disorder (MDD)

GlobeNewswire March 8, 2021

Xenon Pharmaceuticals Reports 2020 Financial Results and Provides Corporate Update

GlobeNewswire March 1, 2021

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2020 Financial Results

GlobeNewswire February 23, 2021

Xenon Pharmaceuticals Announces Promising New Pre-Clinical Data and Provides Clinical Overview of its XEN1101 Program at ASENT 2021

GlobeNewswire February 22, 2021

Xenon Pharmaceuticals Outlines Key Milestone Opportunities and Planned Leadership Transition in 2021

GlobeNewswire January 14, 2021

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at AES2020, the Virtual Annual Meeting of the American Epilepsy Society

GlobeNewswire December 7, 2020